EORTC-55994-GCG

Randomized phase III study of neoadjuvant chemotherapy followed by surgery vs. concomitant radiotherapy and chemotherapy in FIGO Ib2, IIa > 4 cm or IIb cervical cancer.
Study documentation
Trial StatusClosed for recruitment
DatesDate of activation: 19-Mar-02
Closed on : 01-Jul-14
Data management at EORTCFull
Phase3
Randomized trialYes
TypeNeoadjuvant
Targeted Sample size625
Number of steps1
DrugCisplatin
Study StaffAlessandro Colombo (Study Coordinator) - Ospedale Alessandro Manzoni, Lecco
Stefano Greggi (Study Coordinator) - Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Napoli
Gemma Kenter (Study Coordinator) - Academisch Medisch Centrum - Universiteit van Amsterdam, Amsterdam
Fabio Landoni (Study Coordinator) - Istituto Europeo Di Oncologia, Milano
Corneel Coens (Statistician) - EORTC Headquarters, Brussels
Maarten De Rouck (Data Manager) - EORTC Headquarters, Brussels
Emad Shash (Coordinating Physician) - EORTC Headquarters, Brussels
Ellen Peeters (Project Manager) - EORTC Headquarters, Brussels, ellen.peeters( at )eortc.be, +32 27741082
Type of cancerCervical
Participating GroupsEORTC Gynecological Cancer Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00039338
EudraCT2008-003396-52